Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,208 | -2,541 | -1,755 | 4,028 | 1,698 |
| Depreciation Amortization | 6 | N/A | N/A | N/A | 7 |
| Accounts receivable | 411 | 539 | -738 | -668 | 896 |
| Other Working Capital | -1,139 | 340 | -977 | 131 | 917 |
| Other Operating Activity | 960 | 555 | 1,557 | -3,770 | -4,397 |
| Operating Cash Flow | $-2,970 | $-1,107 | $-1,913 | $-279 | $-879 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,616 | 3,616 | 3,616 | N/A | 660 |
| Other Financing Activity | -58 | -58 | -58 | 0 | -18 |
| Financing Cash Flow | $3,558 | $3,558 | $3,558 | $N/A | $642 |
| Beginning Cash Position | 281 | 281 | 281 | 281 | 518 |
| End Cash Position | 869 | 2,732 | 1,926 | 2 | 281 |
| Net Cash Flow | $588 | $2,451 | $1,645 | $-279 | $-237 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,970 | -1,107 | -1,913 | -279 | -879 |
| Free Cash Flow | -2,970 | -1,107 | -1,913 | -279 | -879 |